TrialJournal of thrombosis and haemostasis : JTH2020

Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1).

Robert Klamroth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.